Androula Pavli

Androula Pavli

Auto-generated profile, based on publicly available information

Androula Pavli

Travel Medicine Department, National Public Health Organization, Athens, Greece

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
APAndroula Pavli
Androula Pavli
PSParaskevi Smeti
Paraskevi Smeti
KPKalliopi Papadima
Kalliopi Papadima
AAAnastasia Andreopoulou
Anastasia Andreopoulou
SHSofia Hadjianastasiou
Sofia Hadjianastasiou
Helena MaltezouHelena Maltezou
Helena Maltezou
This report describes a cluster of SARS-CoV-2 infections in pilgrims returning from Israel to Greece. Out of 53 pilgrims, 48 (90.5%) were tested positive for SARS-CoV-2; of them, 41 (85.4%) developed symptoms consistent with COVID-19, and 7 (14.6%) remained asymptomatic. These cases suggest a high risk of COVID-19 infection for pilgrims traveling during the pandemic. Although at that time the prevalence of the disease was low in the origin and destination countries, crowded exposure to other pilgrims from many other countries led to this cluster. Increasing awareness about the risks in pilgrims is important and particularly for elderly pilgrims and those with underlying conditions.

4 April 2022 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
RDRafael Dal-Ré
Rafael Dal-Ré
RBRita Banzi
Rita Banzi
SBSoeren Becker
Soeren Becker
OLOdile Launay
Odile Launay
APAndroula Pavli
Androula Pavli

1 May 2016 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
APAndroula Pavli
Androula Pavli
PKPanagiotis Katerelos
Panagiotis Katerelos
PSParaskevi Smeti
Paraskevi Smeti
Helena MaltezouHelena Maltezou
Helena Maltezou

9 February 2022 in Hormones
Verified
Journal Article
Open access
PDF file
Helena MaltezouHelena Maltezou
Helena Maltezou
APAndroula Pavli
Androula Pavli
PTParaskevi Tsonou
Paraskevi Tsonou
ABAsimina Balaska
Asimina Balaska
VRVASILIOS RAFTOPOULOS
VASILIOS RAFTOPOULOS
NTNikolaos Tentolouris
Nikolaos Tentolouris
Purpose Our aim was to study patients with diabetes mellitus and SARS-CoV-2-infection diagnosed during the first pandemic wave in Greece. Methods Cases were retrieved from the national database of SARS-CoV-2 infections. Results We studied 2624 SARS-CoV-2 infected cases, including 157 with diabetes. Patients with diabetes more often had other comorbidities (68.8 vs. 24.1%; p-value < 0.001). Among patients with diabetes, 149 (94.9%) developed symptomatic disease (COVID-19) compared to 1817 patients (73.7%) without diabetes (p-value < 0.001). A total of 126 patients with diabetes and COVID-19 were hospitalized and 41 died (27.5% case-fatality rate compared to 7.5% among patients without diabetes; p-value < 0.001). Patients with diabetes more often were hospitalized, developed complications, were admitted to the intensive care unit (ICU), received invasive mechanical ventilation, and died compared to patients without diabetes (p-values < 0.001 to 0.002 for all comparisons). Multivariate logistic regression analyses revealed that diabetes, having other comorbidities, and older age were significantly associated with higher risk for hospitalization, ICU admission, invasive mechanical ventilation, and death, and that obesity was significantly associated with higher risk for hospitalization, ICU admission, and mechanical intubation, while female gender protected against these outcomes. Conclusion COVID-19 is associated with increased rates of serious morbidity and adverse outcome in patients with diabetes and represents a severe illness for them.

23 December 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
RDRafael Dal-Ré
Rafael Dal-Ré
SBSoeren Becker
Soeren Becker
OLOdile Launay
Odile Launay
APAndroula Pavli
Androula Pavli